Replies to post #157520 on Biotech Values

[mcbio]

yea, the initial pilot study consisted of only 7 patients in Turkey...so there's that, lol. The results were quite compelling though:

- Intraocular inflammation began to resolve in all 7 patients on Day 1, with a median time to first response of 4 days (range 1 to 14 days)
- Complete resolution of retinal findings was achieved in 4 to 21 days (median 14 days)
- Five out of 7 patients were in remission when they reached the Day 28 visit.

Is it safe to say that those really strong results really only support Eyeguard B and that Eyeguards A and C are much more of a gamble given little underlying prior PoC for these specific indications?